Moderna Vaccine Is Granted Authorization in Australia

Moderna Inc. (NasdaqGS: MRNA) surged Monday after the company’s Covid-19 vaccine was granted a provisional adult authorization in Australia, lifting biotechnology sector-related exchange traded funds. On Monday, the VanEck Vectors Biotech ETF (BBH) rose 3.0% and the iShares Nasdaq...
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.